Testim 1% (testosterone gel) + Placebo
Phase 2Terminated 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypogonadism
Conditions
Hypogonadism
Trial Timeline
Jul 1, 2005 → Jan 1, 2007
NCT ID
NCT00254553About Testim 1% (testosterone gel) + Placebo
Testim 1% (testosterone gel) + Placebo is a phase 2 stage product being developed by Merck for Hypogonadism. The current trial status is terminated. This product is registered under clinical trial identifier NCT00254553. Target conditions include Hypogonadism.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00254553 | Phase 2 | Terminated |
Competing Products
20 competing products in Hypogonadism